General Announcement::We enclose a communication pertaining to USFDA approval

Issuer & Securities

Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$300M4.875%N211006 - XS1493722299 - 4X7B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
09-Feb-2018 17:28:10
Status
New
Announcement Sub Title
We enclose a communication pertaining to USFDA approval
Announcement Reference
SG180209OTHRVZMW
Submitted By (Co./ Ind. Name)
Sanjay Bhartia
Designation
Chief Financial Officer
Effective Date and Time of the event
09/02/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
We enclose a communication pertaining to USFDA approval

Attachments

JPL - USFDA DTPA Approval - 09.02.2018.pdf
Total size =131K